Procalcitonin in 759 Patients Clinically Suspected of Infective Endocarditis
Authors:
- Jane B. KnudsenJKJane B. Knudsen
- Kurt FuurstedKFKurt Fuursted
- Eskild PetersenEPEskild Petersen
- Per WierupPWPer Wierup
- Henning MølgaardHMHenning Mølgaard
- Steen H. PoulsenSPSteen H. Poulsen
- Henrik EgebladHEHenrik Egeblad
- 1 December 2010
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 123 (12) , 1121-1127
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targetBritish Journal of Pharmacology, 2010
- Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract InfectionsJAMA, 2009
- Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)European Heart Journal, 2009
- Infective Endocarditis Prevention: Update on 2007 GuidelinesThe American Journal of Medicine, 2008
- Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitationsCritical Care Medicine, 2008
- Pro-inflammatory cytokines IL6, TNF-α, IL1β, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditisJournal of Infection, 2007
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2006
- Procalcitonin and the Early Diagnosis of Infective EndocarditisCirculation, 2004
- Procalcitonin and C-Reactive Protein in Infective Endocarditis: Correlation with Etiology and PrognosisChemotherapy, 2003
- Duration of symptoms in patients with infective endocarditisInternational Journal of Cardiology, 2003